Home > Insider Trading > Filing (0001181431-12-055549)

Filing Details

Accession Number:: 0001181431-12-055549
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-10-25 17:21:03
Reporting Period:: 2012-10-23

Filing Date:: 2012-10-25
Accepted Time:: 2012-10-25 17:21:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1062822	Lexicon Pharmaceuticals Inc.	LXRX	Pharmaceutical Preparations (2834)	760474169

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1053906	S.a. Group Artal	10-12 Avenue Pasteur Luxembourg N4 L-2310	Yes	No	Yes	No
1218180	S.c.a. International Artal	10-12 Avenue Pasteur Luxembourg N4 L-2310	Yes	No	Yes	No
1283968	S.a. Westend	10-12 Avenue Pasteur Luxembourg N4 L-2310	Yes	No	Yes	No
1340096	Invus Public Equities Advisors, Llc	750 Lexington Avenue, 30Th Floor New York NY 10022	Yes	No	Yes	No
1340097	Invus Public Equities, L.p.	Clarendon House, 2 Church Street Hamilton Hm Ii D0	Yes	No	Yes	No
1404553	Invus Advisors, L.l.c.	750 Lexington Avenue, 30Th Floor New York NY 10022	Yes	No	Yes	No
1404570	Invus, L.p.	Clarendon House, 2 Church Street Hamilton Hm Ii D0	Yes	No	Yes	No
1460839	Pascal Minne	Place Ste. Gudule, 19 Bruxelles C9 B-1000	Yes	No	Yes	No
1460840	Westend Administratiekantoor Stichting	De Boelelaan 7, Amsterdam P7 NL-1083 HJ	Yes	No	Yes	No
1522131	S.a. Management International Artal	10-12 Avenue Pasteur Luxembourg N4 L-2310	Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-10-23	3,000,000	$2.25	283,154,744	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote

Footnotes

On October 23, 2012, Invus, L.P. agreed to purchase 3,000,000 shares of Issuer common stock from the underwriters in a public offering of Issuer common stock. The purchase closed on October 23, 2012.
247,818,843 of the reported shares of Issuer common stock are owned directly by Invus, L.P., 29,782,609 of the reported shares of Issuer common stock are owned directly by Invus C.V. and 5,553,292 of the reported shares of Issuer common stock are owned directly by Invus Public Equities, L.P. Invus Advisors, L.L.C. is the general partner of Invus, L.P., and Invus Public Equities Advisors, LLC is the general partner of Invus Public Equities, L.P. Artal International S.C.A. is the managing member of each of Invus Advisors, L.L.C. and Invus Public Equities Advisors, LLC. Artal International Management S.A. is the managing partner of Artal International S.C.A., which is a wholly owned subsidiary of Artal Group S.A., which is a wholly owned subsidiary of Westend S.A., which is a wholly owned subsidiary of Stichting Administratiekantoor Westend (the "Stichting"). (Continued in footnote 3)
Mr. Pascal Minne is the sole member of the board of the Stichting. Ulys, L.L.C. is the general partner of Invus C.V., and Mr. Raymond Debbane is the sole member of Ulys, L.L.C. Accordingly, each of the Reporting Persons may be deemed to be beneficial owners of some or all of the reported securities. Each of the Reporting Persons disclaims beneficial ownership of such securities, except to the extent of its or his pecuniary interest therein.